Fulcrum Therapeutics Inc - ESG Rating & Company Profile powered by AI
The webpage contains a questions and answers section on Fulcrum Therapeutics Inc. This assessment of Fulcrum Therapeutics Inc employs data from across the web and also from public filings by Fulcrum Therapeutics Inc. Full Sustainability analysis of Fulcrum Therapeutics Inc can be reached by signing up for free.
Fulcrum Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 2.7, social score of 3.2 and governance score of 6.0.
4.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
| 989 | Tricida Inc | 4.1 | High |
| 1004 | Fulcrum Therapeutics Inc | 4.0 | High |
| 1004 | Can B Corp | 4.0 | High |
| 1004 | CLS Holdings USA Inc | 4.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Fulcrum Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Fulcrum Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Fulcrum Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Fulcrum Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Fulcrum Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Fulcrum Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Fulcrum Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Fulcrum Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has research and discovery collaboration agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and has a strategic collaboration and license agreement with MyoKardia, Inc. to discover, develop, and commercialize novel targeted therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.